{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:00:29Z","timestamp":1778508029355,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.comppsych.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T02:06:57Z","timestamp":1475374017000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2612-4119","authenticated-orcid":false,"given":"Francesco","family":"Bartoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-2107","authenticated-orcid":false,"given":"Cristina","family":"Crocamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-3862","authenticated-orcid":false,"given":"Antonios","family":"Dakanalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Brosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-499X","authenticated-orcid":false,"given":"Enrico","family":"Capuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-6169","authenticated-orcid":false,"given":"Giuseppe","family":"Carr\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2016.09.011_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: an overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0020","first-page":"1380","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"2011","author":"Gomes","year":"1808","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2015.10.032","article-title":"Purinergic receptors in psychiatric disorders","volume":"104","author":"Kr\u00fcgel","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1566524015666150330163724","article-title":"Purinergic signaling and energy homeostasis in psychiatric disorders","volume":"15","author":"Lindberg","year":"2015","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","article-title":"Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics","volume":"57","author":"Ortiz","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.1999.tb07983.x","article-title":"Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases","volume":"890","author":"Abbracchio","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania","volume":"32","author":"Machado-Vieira","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/msj.20042","article-title":"Bipolar disorder: candidate drug targets","volume":"75","author":"Zarate","year":"2008","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004714-200112000-00017","article-title":"Therapeutic efficacy of allopurinol in mania associated with hyperuricemia","volume":"21","author":"Machado-Vieira","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2013.06.038","article-title":"Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators","volume":"149","author":"Hirota","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0080","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0085","first-page":"981","article-title":"Increased uric acid levels in bipolar disorder: is it trait or state?","volume":"27","author":"Kesebir","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","article-title":"Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium","volume":"225","author":"Muti","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","article-title":"Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis","volume":"81","author":"Bartoli","year":"2016","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpsychores.2016.03.014","article-title":"Exploring the association between bipolar disorder and uric acid: a mediation analysis","volume":"84","author":"Bartoli","year":"2016","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0105","first-page":"315","article-title":"TBARs and non-enzymatic antioxidant parameters in Tunisian bipolar I patients","volume":"27","author":"Ezzaher","year":"2012","journal-title":"Immuno Anal Biol Spe"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0110","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1681\/ASN.2008091012","article-title":"Uric acid levels increase risk for new-onset kidney disease","volume":"19","author":"Mohandas","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-5996-4-12","article-title":"High plasma uric acid concentration: causes and consequences","volume":"4","author":"de Oliveira","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0120","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0125","series-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.genhosppsych.2014.08.005","article-title":"Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study","volume":"36","author":"Clerici","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jad.2014.11.005","article-title":"Increased uric acid levels in bipolar disorder subjects during different phases of illness","volume":"173","author":"Albert","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2014.04.053","article-title":"Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament","volume":"165","author":"Kesebir","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","article-title":"Serum uric acid levels and the clinical characteristics of depression","volume":"45","author":"Wen","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eurpsy.2013.05.006","article-title":"Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes","volume":"29","author":"Wiener","year":"2014","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0155","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2174\/156802611795347654","article-title":"The role of adenosine in the regulation of sleep","volume":"11","author":"Huang","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.20761","article-title":"Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey","volume":"52","author":"Choi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.semnephrol.2011.08.004","article-title":"The epidemiology of uric acid and fructose","volume":"31","author":"Rho","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.semarthrit.2016.01.003","article-title":"Effects of coffee consumption on serum uric acid: systematic review and meta-analysis","volume":"45","author":"Park","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0175","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.2174\/138161205774913309","article-title":"Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia","volume":"11","author":"Daskalopoulou","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0185","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: a dose\u2013response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0190","first-page":"515","article-title":"Lithium treatment for bipolar disorder","volume":"78","author":"Mitchell","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"Suppl. 2","key":"10.1016\/j.comppsych.2016.09.011_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11","author":"Shorter","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.comppsych.2016.09.011_bb0200","article-title":"Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials","author":"Bartoli","year":"2016","journal-title":"Br J Psychiatry"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X1630503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X1630503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T20:29:37Z","timestamp":1536352177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X1630503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"alternative-id":["S0010440X1630503X"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.09.011","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}